Tokyo - Delayed Quote JPY

Astena Holdings Co., Ltd. (8095.T)

Compare
543.00 -15.00 (-2.69%)
At close: 3:15 PM GMT+9
Loading Chart for 8095.T
DELL
  • Previous Close 558.00
  • Open 555.00
  • Bid 543.00 x --
  • Ask 545.00 x --
  • Day's Range 541.00 - 555.00
  • 52 Week Range 424.00 - 576.00
  • Volume 185,300
  • Avg. Volume 78,648
  • Market Cap (intraday) 21.493B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 13.24
  • EPS (TTM) 41.01
  • Earnings Date Jul 12, 2024
  • Forward Dividend & Yield 18.00 (3.23%)
  • Ex-Dividend Date Nov 28, 2024
  • 1y Target Est --

Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. This division also offers 1,3-butylene glycol, natural plant extract, sodium acetylated hyaluronate, tea-tree oil, yeast extract, dehydrate potato, tomato powder, and meat extract powder. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co., Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.

www.astena-hd.com

1,404

Full Time Employees

November 30

Fiscal Year Ends

Recent News: 8095.T

View More

Performance Overview: 8095.T

Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

8095.T
16.24%
Nikkei 225
18.28%

1-Year Return

8095.T
26.09%
Nikkei 225
19.25%

3-Year Return

8095.T
7.44%
Nikkei 225
36.27%

5-Year Return

8095.T
31.52%
Nikkei 225
86.05%

Compare To: 8095.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8095.T

View More

Valuation Measures

Annual
As of 6/27/2024
  • Market Cap

    22.09B

  • Enterprise Value

    33.00B

  • Trailing P/E

    13.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    0.77

  • Enterprise Value/Revenue

    0.63

  • Enterprise Value/EBITDA

    15.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.07%

  • Return on Assets (ttm)

    1.62%

  • Return on Equity (ttm)

    5.83%

  • Revenue (ttm)

    52.62B

  • Net Income Avi to Common (ttm)

    1.62B

  • Diluted EPS (ttm)

    41.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.67B

  • Total Debt/Equity (mrq)

    54.33%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8095.T

View More

Company Insights: 8095.T

Research Reports: 8095.T

View More

People Also Watch